Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HP1BP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PHTF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EFCAB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DTD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPAST - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BBIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS41 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929612 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCYOX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LNPK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC138 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TGFBR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
OPA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHML - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS13A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on